Sunday, November 8, 2026
The top medical stories of the day, as they ran.
Morning edition
14 stories
- 1ZEUS trial finds ziltivekimab lowered inflammation but not cardiovascular eventsResearch · 7 outlets
- 2Novartis reports nine tumor cases in children treated with ZolgensmaDrug safety · 4 outlets
- 3US reports 5,182 measles cases, highest annual count since 1991Infectious disease · 5 outlets
- 4Former health adviser accuses White House officials of favoring industryHealth policy · 4 outlets
- 5Intensive BP Lowering, Yoga-Based Cardiac Rehab Highlighted Among Late-Breaking Science at AHA 2026Research · 2 outlets
- 6AHA stroke trials report findings on blood pressure and clot preventionResearch · 3 outlets
- 7FDA approves Rybrevant Faspro for recurrent or metastatic head and neck cancerDrugs and FDA · 4 outlets
- 8CMS finalizes 2027 hospital payment rule with 340B cuts and site-neutral changesMedicare and Medicaid · 4 outlets
- 9Doctors warn of small breast cancer risk with menopause hormone therapyDrugs and FDA · 2 outlets
- 10Health ISAC warns hospitals after cyberattack on French blood servicePublic health · 2 outlets
- 11FDA urges DPD deficiency discussions before capecitabine or fluorouracil treatmentDrugs and FDA · 1 outlet
- 12Hims & Hers will offer Eli Lilly’s branded obesity drugsDrugs and FDA · 2 outlets
- 13CMS finalizes Medicare physician payment cuts for 2027Medicare and Medicaid · 2 outlets
- 14Revolution reports strong early sales for pancreatic cancer drug RasonqueDrugs and FDA · 2 outlets
Evening edition
12 stories
- 1PAHO to review U.S. measles elimination status amid outbreaksInfectious disease · 5 outlets
- 2Pelacarsen lowered Lp(a) but did not reduce cardiovascular eventsResearch · 7 outlets
- 3Novartis reports nine tumor cases in children treated with ZolgensmaDrug safety · 4 outlets
- 4ZEUS trial finds ziltivekimab lowered inflammation but not cardiovascular eventsResearch · 6 outlets
- 5Former health adviser accuses White House officials of favoring industryHealth policy · 4 outlets
- 6Trial finds stopping statins may be reasonable for some older adultsResearch · 4 outlets
- 7Trials find retatrutide eased knee osteoarthritis pain in people with obesityResearch · 2 outlets
- 8FDA approves Rybrevant Faspro for recurrent or metastatic head and neck cancerDrugs and FDA · 2 outlets
- 9Health ISAC warns hospitals after cyberattack on French blood servicePublic health · 2 outlets
- 10FDA urges DPD deficiency discussions before capecitabine or fluorouracil treatmentDrugs and FDA · 1 outlet
- 11Hims & Hers will offer Eli Lilly’s branded obesity drugsDrugs and FDA · 2 outlets
- 12Houston Rx recalls compounded sermorelin and tirzepatide productsDrug safety · 1 outlet